NovoCure Limited Operating Lease Right-of-Use Assets
NovoCure Limited (NVCR) had Operating Lease Right-of-Use Assets of $43.79 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-23
- 2026-06-30: Operating Lease, Right-of-Use Asset $43.79M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $45.48M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $47.33M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $48.40M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $43.79M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $45.48M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $47.33M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $48.40M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $48.09M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $48.51M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $27.12M 10-K · filed 2026-02-26 |
| 2024-09-30 | $28.33M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $29.08M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $32.99M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $34.84M 10-K · filed 2025-02-27 |
| 2023-09-30 | $29.01M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $26.28M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $25.53M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $23.60M 10-K · filed 2024-02-22 |
| 2022-09-30 | $19.41M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $18.28M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $19.94M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $18.27M 10-K · filed 2023-02-23 |
| 2021-09-30 | $16.46M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $16.96M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $17.74M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $19.01M 10-K · filed 2022-02-24 |
| 2020-09-30 | $17.12M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $17.43M 10-Q/A · filed 2020-10-02 |
| 2020-03-31 | $17.20M 10-Q/A · filed 2020-10-02 |
| 2019-12-31 | $17.57M 10-K · filed 2021-02-25 |
| 2019-09-30 | $14.63M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $14.66M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $13.92M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $0.00 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |